Understanding Tardive Dyskinesia and Treatment Options

Tardive dyskinesia (TD) is characterized by uncontrollable movements that can cause embarrassment and frustration for those affected. A treatment option, Ingressa, has been clinically proven to reduce TD in adults, administered as one capsule daily. Ingressa allows patients to continue taking most mental health medications, providing a sense of normalcy in their treatment. However, it is important for patients to be aware of potential serious side effects, including risks of depression and suicidal thoughts, especially in patients with Huntington's disease.